Inventor · disambiguated record
Sally Ishizaka
Also filed as: ISHIZAKA SALLY · ISHIZAKA SALLY T
19 granted patents·7 pending applications·273 citations·filing 2000–2021
94Inventor score
Top patents by PatentIndex Score
26 records- 0197US9428495B2Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2014·Granted Aug 30, 2016·35 cites·32 claims
- 0293US9126999B2Tetrahydropyrazolopyrimidine compoundsBOIVIN ROCH·Filed 2013·Granted Sep 8, 2015·33 cites·28 claims
- 0392US8354400B2Benzoxazole compounds and methods of useEISAI R&D MAN CO LTD·Filed 2009·Granted Jan 15, 2013·29 cites·21 claims
- 0490US9446046B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2015·Granted Sep 20, 2016·8 cites·6 claims
- 0590US6551600B2Immunological adjuvant compounds compositions and methods of use thereofEISAI CO LTD·Filed 2001·Granted Apr 22, 2003·37 cites·16 claims
- 0690US6521776B2Immunological adjuvant compounds compositions and methods of use thereofEISAI CO LTD·Filed 2001·Granted Feb 18, 2003·29 cites·16 claims
- 0790US6290973B1Immunological adjuvant compounds, compositions, and methods of use thereofEISAI CO LTD·Filed 2000·Granted Sep 18, 2001·64 cites·13 claims
- 0886US6835721B2Immunomodulatory compounds and methods of use thereofEISAI CO LTD·Filed 2002·Granted Dec 28, 2004·22 cites·36 claims
- 0983US10640500B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2017·Granted May 5, 2020·1 cites·5 claims
- 1083US9850242B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2016·Granted Dec 26, 2017·3 cites·12 claims
- 1182US7976852B2Compositions and methods for cancer immunotherapyEISAI R&D MAN CO LTD·Filed 2006·Granted Jul 12, 2011·2 cites·27 claims
- 1279US7560584B2Immunomodulatory compounds and methods of use thereofEISAI R&D MAN CO LTD·Filed 2004·Granted Jul 14, 2009·8 cites·1 claims
- 1373US7833993B2Immunomodulatory compounds and methods of use thereofEISAI R&D MAN CO LTD·Filed 2005·Granted Nov 16, 2010·1 cites·12 claims
- 1470US11130758B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2020·Granted Sep 28, 2021·0 cites·9 claims
- 1567US9663486B2Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2014·Granted May 30, 2017·1 cites·14 claims
- 1665US2014065100A1Compositions and Methods for Cancer ImmunotherapyEISAI R&D MAN CO LTD·Filed 2013·Application pending·0 cites
- 1764US2018354939A1Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2018·Application pending·0 cites
- 1862USRE47193ESelectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2017·Granted Jan 8, 2019·0 cites·32 claims
- 1962US10087174B2Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2017·Granted Oct 2, 2018·0 cites·17 claims
- 2062US2007292418A1Compositions and methods for immunotherapyEISAI CO LTD·Filed 2006·Application pending·0 cites
- 2160US2016326161A1Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2016·Application pending·0 cites
- 2254US7915238B2Immunomodulatory compounds and methods of use thereofEISAI R&D MAN CO LTD·Filed 2006·Granted Mar 29, 2011·0 cites·11 claims
- 2354US2023149537A1Vaccines, adjuvants, and methods of generating an immune responseEISAI R&D MAN CO LTD·Filed 2021·Application pending·0 cites
- 2452US8603482B2Compositions and methods for cancer immunotherapyROSSIGNOL DANIEL P·Filed 2011·Granted Dec 10, 2013·0 cites·12 claims
- 2552US2011243935A1Compositions and Methods for ImmunotherapyEISAI R&D MAN CO LTD·Filed 2011·Application pending·0 cites
- 2648US2004006242A1Immunomodulatory compounds and method of use thereofFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sally Ishizaka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →